David Einhorn Liva Nova PLC Transaction History

Greenlight Capital Inc

$1.97 Billion
Q4 2023

A detailed history of David Einhorn (Greenlight Capital Inc) transactions in Liva Nova PLC stock. As of the latest transaction made, Greenlight Capital Inc holds 1,229,316 shares of LIVN stock, worth $57.5 Million. This represents 3.23% of its overall portfolio holdings.

Number of Shares

1,229,316

Previous 1,034,896 18.79%

Holding current value

$57.5 Million

Previous $53.2 Million 19.5%

% of portfolio

3.23%

Previous 2.55%

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$43.45 - $53.66 $8.45 Million - $10.4 Million	194,420 Added 18.79%	1,229,316 $63.6 Million
Q1 2023 May 15, 2023	BUY	$40.84 - $58.14 $8.02 Million - $11.4 Million	196,496 Added 23.44%	1,034,896 $45.1 Million
Q4 2022 Feb 14, 2023	BUY	$43.88 - $56.16 $1.14 Million - $1.46 Million	26,000 Added 3.2%	838,400 $46.6 Million
Q3 2022 Nov 14, 2022	BUY	$48.37 - $66.5 $17.6 Million - $24.2 Million	363,800 Added 81.1%	812,400 $41.2 Million
Q2 2022 Aug 15, 2022	BUY	$57.25 - $86.63 $492,350 - $745,018	8,600 Added 1.95%	448,600 $28 Million
Q1 2022 May 16, 2022	BUY	$71.02 - $86.99 $7.03 Million - $8.61 Million	99,000 Added 29.03%	440,000 $36 Million
Q4 2021 Feb 14, 2022	BUY	$76.72 - $92.68 $12.5 Million - $15.2 Million	163,500 Added 92.11%	341,000 $29.8 Million
Q3 2021 Nov 15, 2021	BUY	$76.02 - $88.62 $8.93 Million - $10.4 Million	117,500 Added 195.83%	177,500 $14.1 Million
Q2 2021 Aug 16, 2021	BUY	$73.44 - $87.01 $4.41 Million - $5.22 Million	60,000 New	60,000 $5.05 Million

Others Institutions Holding LIVN

# of Institutions

261

Shares Held

52.9M

Call Options Held

316K

Put Options Held

127K

View Full List

About LivaNova PLC

Ticker LIVN
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 53,545,700
Market Cap $2.5B
Description
LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. It operates through three segments: Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support. The Cardiopulmonary segment develops, produces, and sells cardiopulmonary products, including oxygenators, heart-lung machines,...

More about LIVN

Track David Einhorn's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Greenlight Capital Inc, based on Form 13F filings with the SEC.

News

Stay updated on Greenlight Capital Inc and David Einhorn with notifications on news.

Account